AI based retinal diagnostic startup Leben Care raises funds from IP Ventures

Spread the love

Delhi: Singapore-based Leben Care has raised angel funding from IP Ventures to fight avoidable blindness. The company provides artificial-intelligence (AI) based diagnostic and screening solutions, primarily known for automated, fast and affordable retinal screening.

Leben Care will use the funds to strengthen its product, sales and marketing teams.

Leben Care enables automated analysis of retina image using AI algorithms that can be used by technicians, nurses, optometrists to conduct basic screening with minimal specialist intervention, delivering real-time reports. The startup will also cater to areas such as Glaucoma and age-related macular edema.

With over 700 million people worldwide at the risk of retinal damage, 200 thousand ophthalmologists and only 35 thousand retina experts, there is a significant supply gap that LebenCare intends to fill with its scalable technology.

The AI startup has already made a market entry in India, Japan, China, Singapore, Africa and Australia through partnerships with distributors & ophthalmology centers across these countries.

It counts St.Johns Medical College, Giridhar Eye Insititute, Mach7, Telomeres, Cosmotec and Tonghua Eye Hospital as some of its partners.

Sankara Eye Foundation’s experts are mentoring Leben Care as they have been closely involved in the product development cycle. It has already made a market entry in India, Japan, China, Singapore, Africa and Australia through partnerships with distributors & ophthalmology centers across these countries.

“We are on a mission to fight avoidable blindness using AI and hope to make this technology available to millions who struggle to get access to basic screening. Our platform Netra.ai is intended to be the go to place for all Ophthalmology related AI solutions,” said Leben Care’s Co-founder Nitin Srivastava.

“In our country and even worldwide, there is a huge supply deficit when it comes to screening and diagnostic ophthalmology services. Leben Care is using AI and scalable technology to address this problem,” said Mitesh Shah, Co-founder – IP Ventures.

(Image source – Leben Care)

Leave a Reply

Your email address will not be published. Required fields are marked *